Pfizer and BioNTech said that the potential COVID-19 vaccine they are developing has been found to be more than 90% effective.

 

"This is a great day for science and humanity," Pfizer chairman and CEO Albert Bourla said.

 

The study found that 94 out of the 43,500 participants in the phase 3 trials were infected.

 

It also showed that the vaccine efficacy rate is above 90%, seven days after the second dose. This means that protection is achieved 28 days after the initiation of the vaccination.

 

However, the percentage of the vaccine efficacy may differ with continued collection of safety data.

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Popular Links

Quick Links

Join Us

Argaam.com Copyright © 2024, Argaam Investment, All Rights Reserved
Call Request